293 related articles for article (PubMed ID: 21717405)
21. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 alpha.
Escobar-Morreale H; Pazos F; Potau N; García-Robles R; Sancho JM; Varela C
Fertil Steril; 1994 Sep; 62(3):521-30. PubMed ID: 8062947
[TBL] [Abstract][Full Text] [Related]
22. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
[TBL] [Abstract][Full Text] [Related]
23. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
25. Functional hyperandrogenism detected by corticotropin and GnRH-analogue stimulation tests in women affected by apparently idiopathic hirsutism.
Rossi R; Tauchmanovà L; Luciano A; Valentino R; Savastano S; Battista C; Di Martino M; Lombardi G
J Endocrinol Invest; 2001; 24(7):491-8. PubMed ID: 11508782
[TBL] [Abstract][Full Text] [Related]
26. Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome.
Gonzalez F; Chang L; Horab T; Stanczyk FZ; Crickard K; Lobo RA
Fertil Steril; 1999 Mar; 71(3):439-44. PubMed ID: 10065779
[TBL] [Abstract][Full Text] [Related]
27. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
Cinar N; Cetinozman F; Aksoy DY; Elcin G; Yildiz BO
J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
[TBL] [Abstract][Full Text] [Related]
28. Ovarian influence on adrenal androgen secretion in polycystic ovary syndrome.
Fruzzetti F; De Lorenzo D; Ricci C; Teti G
Fertil Steril; 1995 Apr; 63(4):734-41. PubMed ID: 7890056
[TBL] [Abstract][Full Text] [Related]
29. Clinical and hormonal features of women with polycystic ovary syndrome living in rural and urban areas.
Katulski K; Czyzyk A; Podkowa N; Podfigurna-Stopa A; Ignaszak N; Paczkowska K; Slawek S; Szpurek D; Meczekalski B
Ann Agric Environ Med; 2017 Sep; 24(3):522-526. PubMed ID: 28954502
[TBL] [Abstract][Full Text] [Related]
30. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
[TBL] [Abstract][Full Text] [Related]
31. Steroid hormone analysis of adolescents and young women with polycystic ovarian syndrome and adrenocortical dysfunction using UPC
Swart AC; du Toit T; Gourgari E; Kidd M; Keil M; Faucz FR; Stratakis CA
Pediatr Res; 2021 Jan; 89(1):118-126. PubMed ID: 32247282
[TBL] [Abstract][Full Text] [Related]
32. Omentin-1 level in adolescents with polycystic ovarian syndrome.
Özgen İT; Oruçlu Ş; Selek S; Kutlu E; Guzel G; Cesur Y
Pediatr Int; 2019 Feb; 61(2):147-151. PubMed ID: 30566253
[TBL] [Abstract][Full Text] [Related]
33. Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.
Maas KH; Chuan S; Harrison E; Cook-Andersen H; Duleba AJ; Chang RJ
Fertil Steril; 2016 Oct; 106(5):1252-1257. PubMed ID: 27473350
[TBL] [Abstract][Full Text] [Related]
34. Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (PCOS) and women with non-classic congenital adrenal hyperplasia (NCAH).
Chanukvadze D; Kristesashvili J; Kvashilava N
Iran J Reprod Med; 2012 Jul; 10(4):307-14. PubMed ID: 25246891
[TBL] [Abstract][Full Text] [Related]
35. CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.
Skrgatic L; Baldani DP; Cerne JZ; Ferk P; Gersak K
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):107-12. PubMed ID: 22107839
[TBL] [Abstract][Full Text] [Related]
36. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
Olszanecka-Glinianowicz M; Banaś M; Zahorska-Markiewicz B; Kuglin D; Mokrzycka J; Mentel A
Endokrynol Pol; 2005; 56(6):921-6. PubMed ID: 16821212
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.
Keefe CC; Goldman MM; Zhang K; Clarke N; Reitz RE; Welt CK
PLoS One; 2014; 9(4):e93805. PubMed ID: 24713888
[TBL] [Abstract][Full Text] [Related]
38. Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
Catteau-Jonard S; Bancquart J; Poncelet E; Lefebvre-Maunoury C; Robin G; Dewailly D
Ultrasound Obstet Gynecol; 2012 Aug; 40(2):223-9. PubMed ID: 22648908
[TBL] [Abstract][Full Text] [Related]
39. Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance.
Segal S; Elmadjian M; Takeshige T; Karp S; Mercado R; Rivnay B
Reprod Biomed Online; 2010 May; 20(5):675-80. PubMed ID: 20231113
[TBL] [Abstract][Full Text] [Related]
40. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood.
Rosenfield RL; Ehrmann DA; Littlejohn EE
J Clin Endocrinol Metab; 2015 Apr; 100(4):1537-43. PubMed ID: 25675386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
